Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors.

Maloney N, Giannikou K, Lefferts J, Bridge JA, Linos K.

Hum Pathol. 2018 Dec;82:125-130. doi: 10.1016/j.humpath.2018.03.023. Epub 2018 Apr 4.

PMID:
29626599
2.

Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: A review.

Maloney NJ, Hisaw LD, Worswick S.

J Am Acad Dermatol. 2018 Sep;79(3):585-587. doi: 10.1016/j.jaad.2018.02.063. Epub 2018 Mar 5. No abstract available.

PMID:
29518460
3.

Therapeutic plasma exchange for thrombotic thrombocytopenic purpura with refractory thrombocytopenia.

Maloney N, Martin I, Szczepiorkowski ZM, Dunbar NM.

J Clin Apher. 2018 Jun;33(3):436-438. doi: 10.1002/jca.21612. Epub 2017 Dec 22.

PMID:
29270999
4.

Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.

Maloney NJ, Hisaw LD, Worswick S.

Dermatol Ther. 2017 Nov;30(6). doi: 10.1111/dth.12559. Epub 2017 Oct 15.

PMID:
29034547
5.

Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus.

Harlow ML, Maloney N, Roland J, Guillen Navarro MJ, Easton MK, Kitchen-Goosen SM, Boguslawski EA, Madaj ZB, Johnson BK, Bowman MJ, D'Incalci M, Winn ME, Turner L, Hostetter G, Galmarini CM, Aviles PM, Grohar PJ.

Cancer Res. 2016 Nov 15;76(22):6657-6668. doi: 10.1158/0008-5472.CAN-16-0568. Epub 2016 Oct 3.

6.

18F-FLT Positron Emission Tomography (PET) is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing Sarcoma.

Osgood CL, Tantawy MN, Maloney N, Madaj ZB, Peck A, Boguslawski E, Jess J, Buck J, Winn ME, Manning HC, Grohar PJ.

Sci Rep. 2016 Sep 27;6:33926. doi: 10.1038/srep33926.

7.

Nurse perspectives on the implementation of routine telemonitoring for high-risk diabetes patients in a primary care setting.

Vest BM, Hall VM, Kahn LS, Heider AR, Maloney N, Singh R.

Prim Health Care Res Dev. 2017 Jan;18(1):3-13. Epub 2016 Jun 8.

PMID:
27269513
8.

Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor.

Osgood CL, Maloney N, Kidd CG, Kitchen-Goosen S, Segars L, Gebregiorgis M, Woldemichael GM, He M, Sankar S, Lessnick SL, Kang M, Smith M, Turner L, Madaj ZB, Winn ME, Núñez LE, González-Sabín J, Helman LJ, Morís F, Grohar PJ.

Clin Cancer Res. 2016 Aug 15;22(16):4105-18. doi: 10.1158/1078-0432.CCR-15-2624. Epub 2016 Mar 15.

9.

Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma.

Grohar PJ, Kim S, Rangel Rivera GO, Sen N, Haddock S, Harlow ML, Maloney NK, Zhu J, O'Neill M, Jones TL, Huppi K, Grandin M, Gehlhaus K, Klumpp-Thomas CA, Buehler E, Helman LJ, Martin SE, Caplen NJ.

Cell Rep. 2016 Jan 26;14(3):598-610. doi: 10.1016/j.celrep.2015.12.063. Epub 2016 Jan 14.

10.

Impact of electronic diabetes registry 'Meaningful Use' on quality of care and hospital utilization.

Han W, Sharman R, Heider A, Maloney N, Yang M, Singh R.

J Am Med Inform Assoc. 2016 Mar;23(2):242-7. doi: 10.1093/jamia/ocv040. Epub 2015 Jul 1.

PMID:
26133895
11.

Nanomechanical sensors for single microbial cell growth monitoring.

Maloney N, Lukacs G, Jensen J, Hegner M.

Nanoscale. 2014 Jul 21;6(14):8242-9. doi: 10.1039/c4nr01610f.

PMID:
24931547
12.

Device for filamentous fungi growth monitoring using the multimodal frequency response of cantilevers.

Maloney N, Lukacs G, Ball SL, Hegner M.

Rev Sci Instrum. 2014 Jan;85(1):015003. doi: 10.1063/1.4854655.

PMID:
24517802
13.

Creating a connected community: lessons learned from the Western new york beacon community.

Maloney N, Heider AR, Rockwood A, Singh R.

EGEMS (Wash DC). 2014 Oct 27;2(3):1091. eCollection 2014.

14.

Developing a communitywide electronic health record disease registry in primary care practices: lessons learned from the Western new york beacon community.

Heider AR, Maloney NA, Satchidanand N, Allen GM, Mueller R, Gangloff S, Singh R.

EGEMS (Wash DC). 2014 Sep 4;2(3):1089. doi: 10.13063/2327-9214.1089. eCollection 2014.

15.

Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin.

Wang SS, Hsiao R, Limpar MM, Lomahan S, Tran TA, Maloney NJ, Ikegaki N, Tang XX.

Int J Mol Med. 2014 Jan;33(1):35-42. doi: 10.3892/ijmm.2013.1545. Epub 2013 Nov 1.

16.

Essential cell-autonomous role for interferon (IFN) regulatory factor 1 in IFN-γ-mediated inhibition of norovirus replication in macrophages.

Maloney NS, Thackray LB, Goel G, Hwang S, Duan E, Vachharajani P, Xavier R, Virgin HW.

J Virol. 2012 Dec;86(23):12655-64. doi: 10.1128/JVI.01564-12. Epub 2012 Sep 12.

17.

Nondegradative role of Atg5-Atg12/ Atg16L1 autophagy protein complex in antiviral activity of interferon gamma.

Hwang S, Maloney NS, Bruinsma MW, Goel G, Duan E, Zhang L, Shrestha B, Diamond MS, Dani A, Sosnovtsev SV, Green KY, Lopez-Otin C, Xavier RJ, Thackray LB, Virgin HW.

Cell Host Microbe. 2012 Apr 19;11(4):397-409. doi: 10.1016/j.chom.2012.03.002.

18.

Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine.

Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, Storer CE, Head RD, Xavier R, Stappenbeck TS, Virgin HW.

Cell. 2010 Jun 25;141(7):1135-45. doi: 10.1016/j.cell.2010.05.009.

19.

Insulin requirements in the intensive care unit in response to infection.

Maloney N, Britt RC, Rushing GD, Reed SF, Cole FC, Collins JN, Weireter LJ, Britt LD.

Am Surg. 2008 Sep;74(9):845-8.

PMID:
18807675
20.

Changes in male breast cancer over a 30-year period.

Schaub NP, Maloney N, Schneider H, Feliberti E, Perry R.

Am Surg. 2008 Aug;74(8):707-11; discussion 711-2.

PMID:
18705571
21.

Environmental exposures and puberty in inner-city girls.

Wolff MS, Britton JA, Boguski L, Hochman S, Maloney N, Serra N, Liu Z, Berkowitz G, Larson S, Forman J.

Environ Res. 2008 Jul;107(3):393-400. doi: 10.1016/j.envres.2008.03.006. Epub 2008 May 13.

22.

Impact of race on breast cancer in lower socioeconomic status women.

Maloney N, Koch M, Erb D, Schneider H, Goffman T, Elkins D, Laronga C.

Breast J. 2006 Jan-Feb;12(1):58-62.

PMID:
16409588
23.

Acute intestinal pseudo-obstruction (Ogilvie's syndrome).

Maloney N, Vargas HD.

Clin Colon Rectal Surg. 2005 May;18(2):96-101. doi: 10.1055/s-2005-870890.

24.

Exposure to the anti-TNF-alpha drug thalidomide induces apoptotic cell death in human T leukemic cells.

Ezell TN, Maloney N, Githua JW, Taylor LD.

Cell Mol Biol (Noisy-le-grand). 2003 Nov;49(7):1117-24.

PMID:
14682394
25.

CYP17 genotype and breast cancer risk.

Weston A, Pan CF, Bleiweiss IJ, Ksieski HB, Roy N, Maloney N, Wolff MS.

Cancer Epidemiol Biomarkers Prev. 1998 Oct;7(10):941-4.

26.

Histomorphometric and biochemical characterization of bone following acute severe burns in children.

Klein GL, Herndon DN, Goodman WG, Langman CB, Phillips WA, Dickson IR, Eastell R, Naylor KE, Maloney NA, Desai M, et al.

Bone. 1995 Nov;17(5):455-60.

PMID:
8579956
27.

Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y.

Am J Kidney Dis. 1995 Nov;26(5):836-44.

PMID:
7485142
28.

Effect of temperature and host factors on the activities of pertussis toxin and Bordetella adenylate cyclase.

Murayama T, Hewlett EL, Maloney NJ, Justice JM, Moss J.

Biochemistry. 1994 Dec 27;33(51):15293-7.

PMID:
7803392
29.

Characterization of adenylate cyclase toxin from a mutant of Bordetella pertussis defective in the activator gene, cyaC.

Hewlett EL, Gray MC, Ehrmann IE, Maloney NJ, Otero AS, Gray L, Allietta M, Szabo G, Weiss AA, Barry EM.

J Biol Chem. 1993 Apr 15;268(11):7842-8.

30.

The spectrum of bone disease in end-stage renal failure--an evolving disorder.

Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV.

Kidney Int. 1993 Feb;43(2):436-42.

31.

Effects of 1-week head-down tilt bed rest on bone formation and the calcium endocrine system.

Arnaud SB, Sherrard DJ, Maloney N, Whalen RT, Fung P.

Aviat Space Environ Med. 1992 Jan;63(1):14-20.

PMID:
1550528
32.

Beta 2-microglobulin deposition in bone in chronic renal failure.

Onishi S, Andress DL, Maloney NA, Coburn JW, Sherrard DJ.

Kidney Int. 1991 May;39(5):990-5.

33.

Can caring behavior be taught?

Forsyth D, Delaney C, Maloney N, Kubesh D, Story D.

Nurs Outlook. 1989 Jul-Aug;37(4):164-6. No abstract available.

PMID:
2740255
34.

Single-dose tetracycline labeling for bone histomorphometry.

Sherrard DJ, Maloney NA.

Am J Clin Pathol. 1989 Jun;91(6):682-7.

PMID:
2499180
35.

Bone aluminum accumulation in hemodialysis patients: a longitudinal perspective.

Kopp JB, Andress DL, Maloney NA, Sherrard DJ.

Am J Kidney Dis. 1988 Sep;12(3):214-9.

PMID:
3414677
36.

Reactivation of inhibited bone acid phosphatase and its significance in bone histomorphometry.

Liu CC, Sherrard DJ, Maloney NA, Howard GA.

J Histochem Cytochem. 1987 Dec;35(12):1355-63.

PMID:
3680930
37.

Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.

Andress DL, Maloney NA, Coburn JW, Endres DB, Sherrard DJ.

J Clin Endocrinol Metab. 1987 Jul;65(1):11-6.

PMID:
3584392
38.

Early deposition of aluminum in bone in diabetic patients on hemodialysis.

Andress DL, Kopp JB, Maloney NA, Coburn JW, Sherrard DJ.

N Engl J Med. 1987 Feb 5;316(6):292-6.

PMID:
3807961
39.

Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy.

Andress DL, Endres DB, Maloney NA, Kopp JB, Coburn JW, Sherrard DJ.

J Clin Endocrinol Metab. 1986 Nov;63(5):1163-9.

PMID:
3760116
40.

Survival skills for the acting dean.

Maloney NW.

Nurs Outlook. 1986 Nov-Dec;34(6):289-91. No abstract available.

PMID:
3640344
41.

Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.

Andress DL, Maloney NA, Endres DB, Sherrard DJ.

J Bone Miner Res. 1986 Oct;1(5):391-8.

PMID:
3503554
42.

Changes in bone histology after treatment with desferrioxamine.

Ott SM, Andress DL, Nebeker HG, Milliner DS, Maloney NA, Coburn JW, Sherrard DJ.

Kidney Int Suppl. 1986 Feb;18:S108-13. No abstract available.

PMID:
3457986
43.

Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure.

Andress DL, Ott SM, Maloney NA, Sherrard DJ.

N Engl J Med. 1985 Feb 21;312(8):468-73.

PMID:
3969109
44.

Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition.

Ott SM, Maloney NA, Klein GL, Alfrey AC, Ament ME, Coburn JW, Sherrard DJ.

Ann Intern Med. 1983 Jun;98(6):910-4.

PMID:
6407375
45.

The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy.

Ott SM, Maloney NA, Coburn JW, Alfrey AC, Sherrard DJ.

N Engl J Med. 1982 Sep 16;307(12):709-13.

PMID:
6896740
46.

Bone aluminum and histomorphometric features of renal osteodystrophy.

Hodsman AB, Sherrard DJ, Alfrey AC, Ott S, Brickman AS, Miller NL, Maloney NA, Coburn JW.

J Clin Endocrinol Metab. 1982 Mar;54(3):539-46.

PMID:
7056841
47.

Histological quantitation of aluminum in iliac bone from patients with renal failure.

Maloney NA, Ott SM, Alfrey AC, Miller NL, Coburn JW, Sherrard DJ.

J Lab Clin Med. 1982 Feb;99(2):206-16.

PMID:
6174656
48.

Aluminum as a factor in the bone disease of long-term parenteral nutrition.

Klein GL, Ott SM, Alfrey AC, Sherrard DJ, Hazlet TK, Miller NL, Maloney NA, Berquist WE, Ament ME, Coburn JW.

Trans Assoc Am Physicians. 1982;95:155-64. No abstract available.

PMID:
6820740
49.

Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure.

Sherrard DJ, Coburn JW, Brickman AS, Singer FR, Maloney N.

Contrib Nephrol. 1980;18:92-7. No abstract available.

PMID:
7353382
50.

Bone biopsy to diagnose hyperoxaluria in patients with renal failure.

Mathews M, Stauffer M, Cameron EC, Maloney N, Sherrard DJ.

Ann Intern Med. 1979 May;90(5):777-9.

PMID:
434679

Supplemental Content

Loading ...
Support Center